A phase II clinical trial of nivolumab and temozolomide for neuroendocrine neoplasms (NEN): updated overall survival data
Year: 2023
Type: conference-abstract
Source: Endocrine Abstracts
Authors: Dwight H. Owen, Vineeth Sukrithan, Brooke Benner, Lai Wei, Ashima Goyal, Ye Zhou, Carly Pilcher, Nancy Curtis, Megan Jukich, Emily Schwarz, Himanshu Savardekar, Ruthann Norman, Sarah Ferguson, Barbara Kleiber, Robert Wesolowski, William E. Carson, A. Otterson III, Gregory, Claire F. Verschraegen, Manisha H. Shah, Bhavana Konda
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389918869